US · PDEX
Pro-Dex, Inc.
- Sector
- Healthcare · Medical - Instruments & Supplies
- Headquarters
- Irvine, CA 92614
- Website
- pro-dex.com
Price · as of 2025-06-30
$48.36
Market cap 144.54M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $632.92 | +1,208.77% |
| Intrinsic Value(DCF) | $46.37 | -4.11% |
| Graham-Dodd Method(GD) | $24.80 | -48.73% |
| Graham Formula(GF) | $83.84 | +73.37% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $1.78 | $152.13 | $5.52 | $7.21 | $19.57 |
| 2012 | $1.85 | $439.07 | $0.00 | $1.58 | $7.14 |
| 2013 | $1.98 | $11,421.90 | $0.00 | $0.00 | $10.53 |
| 2014 | $2.07 | $340.94 | $0.38 | $1.94 | $0.44 |
| 2015 | $2.35 | $63.95 | $0.00 | $1.57 | $0.00 |
| 2016 | $5.25 | $567.18 | $62.78 | $3.11 | $11.22 |
| 2017 | $7.50 | $186.26 | $129.75 | $9.66 | $20.82 |
| 2018 | $9.75 | $55.99 | $60.78 | $5.90 | $3.93 |
| 2019 | $13.89 | $40.88 | $83.12 | $8.92 | $27.92 |
| 2020 | $28.69 | $74.10 | $190.24 | $12.69 | $54.86 |
| 2021 | $24.26 | $474.73 | $253.82 | $12.72 | $33.52 |
| 2022 | $20.15 | $37.44 | $65.17 | $13.28 | $10.22 |
| 2023 | $16.90 | $2,795.13 | $26.49 | $18.75 | $34.30 |
| 2024 | $23.28 | $54.99 | $12.52 | $11.86 | $14.71 |
| 2025 | $38.19 | $632.92 | $58.25 | $24.80 | $83.84 |
AI valuation
Our deep-learning model estimates Pro-Dex, Inc.'s (PDEX) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $632.92
- Current price
- $48.36
- AI upside
- +1,208.77%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$46.37
-4.11% upside
Graham-Dodd
$24.80
-48.73% upside
Graham Formula
$83.84
+73.37% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| PDEX | Pro-Dex, Inc. | $48.36 | 144.54M | +1,209% | -4% | -49% | +73% | 13.99 | 3.43 | 1.89 | 9.56 | 4.05 | 3.43 | 29.30% | 16.05% | 13.48% | 26.60% | 19.04% | 15.80% | 0.45 | 12.89 | 3.23 | 1.68 | 1.14 | 34500.00% | 2368.00% | -15613.00% | -2.33% | -0.11 | -7.00% | 0.00% | 0.00% | 2.79% | 12.63 | -46.10 | 2.03 | 6.19 |
| APYX | Apyx Medical Corporation | $3.27 | 134.17M | +662% | -86% | — | — | -1.69 | 2.80 | 0.83 | -2.79 | -7.60 | 2.80 | 61.04% | -39.18% | -48.78% | -115.17% | -88.10% | -32.70% | 2.73 | -3.19 | 5.26 | 4.40 | -0.42 | 2222.00% | -811.00% | 22461.00% | -47.15% | -1.68 | -87.74% | 0.00% | 0.00% | 0.00% | -2.49 | -2.50 | 0.97 | -0.58 |
| CGTX | Cognition Therapeutics, I… | $1.09 | 80.2M | — | — | — | — | -0.50 | 0.91 | — | 0.21 | — | 0.91 | 0.00% | — | — | -157.19% | 1117.89% | -103.89% | 0.04 | -2158.64 | 2.65 | 2.49 | 0.72 | -116.00% | — | 7617.00% | -167.08% | -2.56 | 589.91% | 0.00% | 0.00% | 0.00% | 0.13 | 0.25 | — | -12.38 |
| GLSI | Greenwich LifeSciences, I… | $27.72 | 384.05M | — | — | — | — | -9.97 | 62.14 | — | -9.72 | -13.23 | 62.19 | 0.00% | — | — | -341.95% | 1733.85% | -284.78% | 0.00 | — | 2.62 | 2.62 | 0.26 | 7536.00% | — | 1216.00% | -4.61% | -4.66 | 786.86% | 0.00% | 0.00% | 0.00% | -9.58 | -21.11 | — | 25.79 |
| IXHL | Incannex Healthcare Limit… | $4.24 | 48.7M | +3,609% | +49% | — | — | -0.39 | 1.35 | 210.33 | -0.07 | -0.04 | 1.35 | 100.00% | -27661.63% | -54517.44% | -381.09% | -1055.21% | -250.09% | 0.02 | -78.51 | 2.86 | 2.82 | 0.31 | 109298.00% | 37870.00% | -2234.00% | -69.22% | -1.79 | -577.00% | 0.00% | 0.00% | 51.39% | -0.14 | -0.26 | 38.46 | -12.32 |
| LUCD | Lucid Diagnostics Inc. | $1.44 | 146.54M | +85,309% | -60% | — | — | -1.54 | 13.02 | 16.16 | -1.56 | — | 15.08 | -90.20% | -1059.64% | -1047.61% | -2956.43% | 5531.77% | -157.04% | 3.94 | -1771.23 | 1.07 | 0.97 | 0.02 | -1667.00% | 7900.00% | 3556.00% | -63.78% | -1.88 | 5379.70% | 0.00% | 0.00% | 0.00% | -1.50 | -1.54 | 15.90 | -12.37 |
| MBOT | Microbot Medical Inc. | $2.41 | 109.82M | — | — | — | — | -1.98 | 6.43 | — | -1.53 | — | 6.43 | 0.00% | — | — | -284.97% | 667.72% | -159.40% | 0.03 | — | 2.37 | 2.35 | 0.26 | -3048.00% | — | 334.00% | -39.02% | -3.59 | 508.44% | 0.00% | 0.00% | 3.38% | -1.49 | -1.96 | — | -21.36 |
| RPID | Rapid Micro Biosystems, I… | $4.33 | 191.92M | +463% | -78% | — | — | -2.22 | 1.38 | 3.71 | -1.28 | — | 1.38 | -0.39% | -177.96% | -167.16% | -48.50% | -155.83% | -38.81% | 0.08 | — | 4.61 | 3.32 | 0.23 | -1148.00% | 2457.00% | -300.00% | -43.71% | -2.51 | -142.09% | 0.00% | 0.00% | 0.00% | -1.19 | -1.31 | 2.12 | -4.66 |
| SERA | Sera Prognostics, Inc. | $2.29 | 86.17M | +1,463% | -17% | — | +2,648% | -4.35 | 3.00 | 1860.23 | -3.05 | — | 3.06 | -6.49% | -47577.92% | -42724.68% | -55.78% | -289.10% | -39.16% | 0.02 | -1308.39 | 1.92 | 1.87 | 0.10 | -1466.00% | -7484.00% | -4403.00% | -10.67% | -0.57 | -120.66% | 0.00% | 0.00% | 0.82% | -2.67 | -6.40 | 1270.67 | -3.22 |
| STSS | Sharps Technology, Inc. | $1.73 | 50.16M | — | — | — | — | -0.04 | 0.19 | — | -0.48 | -0.01 | 0.19 | 0.00% | — | — | -187.23% | -159.55% | -97.33% | 1.89 | -4.61 | 0.61 | 0.19 | -0.42 | 78195.00% | — | -2322.00% | -1894.69% | -1.34 | -144.00% | 0.00% | 0.00% | 0.00% | -0.42 | -0.46 | — | -10.43 |
| TVGN | Tevogen Bio Holdings Inc. | $0.26 | 53.24M | — | — | — | — | -12.18 | -25.05 | — | -12.85 | -0.05 | -25.05 | 0.00% | — | — | 27.16% | 2087.12% | -306.17% | -0.43 | -291.05 | 0.26 | 0.16 | -0.12 | 2330000.00% | — | 4449.00% | -7.18% | -1.33 | 467.53% | 0.00% | 0.00% | 55.48% | -3.15 | -14.07 | — | -89.34 |
About Pro-Dex, Inc.
Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.
- CEO
- Richard Lee Van Kirk Jr.
- Employees
- 146
- Beta
- -0.02
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($46.37 ÷ $48.36) − 1 = -4.11% (DCF, example).